Empowering Patients With Diabetes and Their Family Members: Assessing the Impact of Free Informative Mobile Messages

NCT ID: NCT06176495

Last Updated: 2024-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-31

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a Randomized Control Trial aiming at investigating the feasibility and effectiveness of a WhatsApp-based informative intervention on Diabetes Mellitus care in Lebanon and exploring the impact of this intervention on various aspects of Diabetes management and patient outcomes.

Family member caregivers will be also included in this interventional study as the research investigators opt to evaluate their DM related knowledge, personal health practices, their involvement in the care of patients with diabetes, and their impact on the patients' diabetes control before and after the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants with diabetes will be equally and randomly divided into an intervention group (patients with diabetes and their designated family member) of individualized WhatsApp groups which will include each participant individually and the study coordinator to protect their privacy; regular, 4-5 diabetes educational messages a week for a total of 12 weeks will be sent by noon (around 12 pm) to the intervention group participants. The other group, control group, will receive no text messages throughout this period. After 3 months, participants of the intervention group (patients with diabetes and their family members) will be asked to fill in a postintervention knowledge and practices questionnaire to delineate any marked differences in the context of knowledge and health behaviors. All participants with diabetes of both groups will be asked to recheck the previously noted clinical and laboratory parameters at 12 weeks to evaluate for any changes particularly among the intervention group who will also be asked to fill out a postintervention survey. After 6 months, all patients with diabetes will be asked to recheck their clinical and laboratory values again and members of the intervention group will be asked to fill in the practices section questionnaire again.

This research will additionally include Family Members of patients with diabetes who are involved in their care (cooking, aiding in management, securing/delivering medications, etc.). Family Member Caregivers of participants will be designated/noted by the participants who have diabetes themselves, and they will be included in the study based on their willingness to take part of the study. They will also be sorted into either a control or an intervention group in accordance with which group their relative with diabetes was sorted into, for example, if the patient with diabetes will be designated to be a part of the intervention group, this means that the family member caregiver participant will also be allocated to the intervention group. Our aim is to evaluate their DM related knowledge, personal health practices, their involvement in the care of patients with diabetes, and their impact on the patients' diabetes control before and after the intervention.

One point to note as well is that to ensure equality among groups and for the benefit of the control group participants, the research investigators will be sharing with them the content of the text messages originally shared with the participants of the intervention group by the End of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Patients with Diabetes and Family Member Caregivers who will receive no text messages over the designated period of the designated

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention Group

Patients with Diabetes and Family Member Caregivers who will receive Educational Text Messages via WhatsApp over the designated period of the intervention

Group Type OTHER

Educational Text Messages

Intervention Type DIAGNOSTIC_TEST

The educational content will be targeted about Diabetes Education and will be guideline based with what complies to the standards of care instituted by the American Diabetes Association.

They text messages will comprise content related to general diabetes knowledge, diabetes management and control, coping with diabetes, and guidance on adopting a healthy lifestyle.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational Text Messages

The educational content will be targeted about Diabetes Education and will be guideline based with what complies to the standards of care instituted by the American Diabetes Association.

They text messages will comprise content related to general diabetes knowledge, diabetes management and control, coping with diabetes, and guidance on adopting a healthy lifestyle.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients 18 years or older
* Patients with an established DM diagnosis
* Patients with a recent HbA1c level with no recent changes in treatment regimen
* Recent HbA1c \> 7 but less than 9
* Patients who are on oral antidiabetic medications or basal insulin (intermediate, long acting, ultra long acting insulin)
* Patients who are adherents to the American University of Beirut Health Insurance Plan (AUB-HIP)
* Patients who have visited the Family Medicine Primary Care Clinics at American University of Beirut Clinics in the past 12 months.
* Patients with smart mobile phones and/or access to WhatsApp services
* Patients who can speak and read Arabic or English or live with someone who can read for them
* Patients with available family members involved in their care (e.g. cooking, aiding in management, securing/delivering medications, having the patient medically insured, etc.).
* Willingness to participate in the study


* Age 18 years or older
* Designated or selected by the participating patient with diabetes.
* Not diagnosed with DM
* Can read and write
* No visual or hearing impairments
* Involved in the participant's diabetes or general care and has an influence on the participant's lifestyle behaviors or medical insurance (e.g. cooking, aiding in management, securing/delivering medications, having the patient medically insured, etc.).
* Access to the WhatsApp service
* Willingness to participate in the study

Exclusion Criteria

* Young patients below 18 years
* Patients who are on non basal insulin/bolus therapy
* Adults with cognitive impairment
* Adults with functional dependence and no assisting family member or caregiver
* Pregnant and Postpartum patients
* Patients with terminal or critical diseases (e.g., cancer; advanced heart, lung, liver, and kidney disease; Human immunodeficiency virus infection and Acquired immune deficiency syndrome and etc.)
* Patients with severe hearing or visual impairment
* Patients who can't read or have difficulty reading and do not live with someone who can read for them
* Patients who will have any of their medications modified throughout the study process will be excluded from the study as well
* Patients with a positive depression (PHQ 2) and/or anxiety (GAD 2) screening results who will be asked to follow up with their primary physician
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American University of Beirut Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Najla El Lakkis

Specialist in Family Medicine; Specialist in Occupational Medicine; Clinical Associate in Family Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Najla El Lakkis, FAM MED

Role: PRINCIPAL_INVESTIGATOR

American University of Beirut Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Najla El Lakkis, FAM MED

Role: CONTACT

01-350000 ext. 3020

Farah Farhat, MD

Role: CONTACT

01-350000 ext. 3020

References

Explore related publications, articles, or registry entries linked to this study.

Al-Mutawaa KA, Farghaly AH, Nasir R, Loares AM, Skaroni I, Al-Thani M, Abou-Samra AB. Level of knowledge, attitude and practice towards diabetes among nationals and long-term residents of Qatar: a cross-sectional study. BMJ Open. 2022 Feb 16;12(2):e052607. doi: 10.1136/bmjopen-2021-052607.

Reference Type BACKGROUND
PMID: 35172997 (View on PubMed)

Abaza H, Marschollek M. SMS education for the promotion of diabetes self-management in low & middle income countries: a pilot randomized controlled trial in Egypt. BMC Public Health. 2017 Dec 19;17(1):962. doi: 10.1186/s12889-017-4973-5.

Reference Type RESULT
PMID: 29258499 (View on PubMed)

Ernawati U, Wihastuti TA, Utami YW. Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review. J Public Health Res. 2021 Apr 14;10(2):2240. doi: 10.4081/jphr.2021.2240.

Reference Type RESULT
PMID: 33855427 (View on PubMed)

Karaoui LR, Deeb ME, Nasser L, Hallit S. Knowledge and practice of patients with diabetes mellitus in Lebanon: a cross-sectional study. BMC Public Health. 2018 Apr 20;18(1):525. doi: 10.1186/s12889-018-5416-7.

Reference Type RESULT
PMID: 29678148 (View on PubMed)

Sahin C, Courtney KL, Naylor PJ, E Rhodes R. Tailored mobile text messaging interventions targeting type 2 diabetes self-management: A systematic review and a meta-analysis. Digit Health. 2019 Apr 22;5:2055207619845279. doi: 10.1177/2055207619845279. eCollection 2019 Jan-Dec.

Reference Type RESULT
PMID: 31041110 (View on PubMed)

Bin Abbas B, Al Fares A, Jabbari M, El Dali A, Al Orifi F. Effect of mobile phone short text messages on glycemic control in type 2 diabetes. Int J Endocrinol Metab. 2015 Jan 1;13(1):e18791. doi: 10.5812/ijem.18791. eCollection 2015 Jan.

Reference Type RESULT
PMID: 25745493 (View on PubMed)

Omar MA, Hasan S, Palaian S, Mahameed S. The impact of a self-management educational program coordinated through WhatsApp on diabetes control. Pharm Pract (Granada). 2020 Apr-Jun;18(2):1841. doi: 10.18549/PharmPract.2020.2.1841. Epub 2020 May 3.

Reference Type RESULT
PMID: 32477434 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735794/

SMS education for the promotion of diabetes self-management in low \& middle income countries: a pilot randomized controlled trial in Egypt

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129774/

Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review

https://www.scielo.br/j/aem/a/VCBKnRL6km3qjGsf3LbFDFg/?lang=en

Educating diabetic patients through an SMS intervention: a randomized controlled trial at a Brazilian public hospital

https://pubmed.ncbi.nlm.nih.gov/29678148/

Knowledge and practice of patients with diabetes mellitus in Lebanon: a cross-sectional study

https://pubmed.ncbi.nlm.nih.gov/35172997/

Level of knowledge, attitude and practice towards diabetes among nationals and long-term residents of Qatar: a cross-sectional study (With KAP Questionnaire)

https://jech.bmj.com/content/68/6/557.long

Disease-related distress, self-care and clinical outcomes among low-income patients with diabetes

https://www.intechopen.com/chapters/75367

Family-Centered Diabetes Care for Better Glycemic Outcomes of Outpatients in Rural Areas

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481002/

Tailored mobile text messaging interventions targeting type 2 diabetes self-management: A systematic review and a meta-analysis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338653/

Effect of Mobile Phone Short Text Messages on Glycemic Control in Type 2 Diabetes

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243744/

The impact of a self-management educational program coordinated through WhatsApp on diabetes control

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SBS-2023-0225

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Texting for Diabetes
NCT03025984 ACTIVE_NOT_RECRUITING NA